RU2004119547A - Кристаллы производных таксана и способ их получения - Google Patents
Кристаллы производных таксана и способ их получения Download PDFInfo
- Publication number
- RU2004119547A RU2004119547A RU2004119547/04A RU2004119547A RU2004119547A RU 2004119547 A RU2004119547 A RU 2004119547A RU 2004119547/04 A RU2004119547/04 A RU 2004119547/04A RU 2004119547 A RU2004119547 A RU 2004119547A RU 2004119547 A RU2004119547 A RU 2004119547A
- Authority
- RU
- Russia
- Prior art keywords
- mixture
- water
- organic solvent
- crystals
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Claims (8)
1. Кристаллы (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-ацетокси-2-бензоилокси-9,10-[(1S)-2-(диметиламино)этилидендиокси]-5,20-эпокси-1-гидрокситакс-11-ен-13-ил(2R,3S)-3-(трет-бутоксикарбониламино)-3-(3-фтор-2-пиридил)-2-гидроксипропионата, которые демонстрируют картину дифракции рентгеновских лучей в порошке с характеристическими пиками при углах дифракции (2θ) равных 6,2°, 10,3°, 10,7°, 11,4° и 12,0°.
2. Способ получения кристаллов по п.1, который включает этап проведения кристаллизации с использованием органического растворителя, выбранного из группы, состоящей из растворителя типа кетона, растворителя типа нитрила и их смеси или смеси указанного органического растворителя и воды.
3. Способ по п. 2, в котором органический растворитель, который выбирают из группы, состоящей из растворителя типа кетона, растворителя типа нитрила и их смеси является органическим растворителем, выбранным из группы, состоящей из ацетона, ацетонитрила, и их смеси.
4. Способ по п. 2, в котором кристаллизацию проводят с использованием смеси ацетона и воды или смеси ацетонитрила и воды.
5. Способ по п. 4, в котором смесь ацетона и воды, или смесь ацетонитрила и воды содержит от 40 до 50% воды по массе.
6. Способ по любому из пп. 2-5, дополнительно включающий стадию сушки кристаллов, полученных кристаллизацией при температуре от 30 до 60°С.
7. Противоопухолевый агент, включающий в качестве активного ингредиента кристалл по п.1.
8. Кристалл по п.1, используемый для получения лекарственного средства, содержащего (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-ацетокси-2-бензоилокси-9,10-[(1S)-2-(диметиламино)этилидендиокси]-5,20-эпокси-1-гидрокситакс-11-ен-13-ил(2R,3S)-3-(трет-бутоксикарбониламино)-3-(3-фтор-2-пиридил)-2-гидроксипропионат, в качестве активного ингредиента.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-363681 | 2001-11-29 | ||
| JP2001363681 | 2001-11-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004119547A true RU2004119547A (ru) | 2005-03-27 |
| RU2284328C2 RU2284328C2 (ru) | 2006-09-27 |
Family
ID=19173983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004119547/04A RU2284328C2 (ru) | 2001-11-29 | 2002-11-29 | Кристаллы производных таксана и способ их получения |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7410980B2 (ru) |
| EP (1) | EP1457492B1 (ru) |
| JP (1) | JP4310191B2 (ru) |
| KR (1) | KR100886805B1 (ru) |
| CN (1) | CN1295229C (ru) |
| AT (1) | ATE382624T1 (ru) |
| AU (1) | AU2002354126A1 (ru) |
| CA (1) | CA2468953C (ru) |
| DE (1) | DE60224440T2 (ru) |
| DK (1) | DK1457492T3 (ru) |
| ES (1) | ES2299612T3 (ru) |
| HK (1) | HK1065547A1 (ru) |
| MX (1) | MXPA04005192A (ru) |
| NO (1) | NO328559B1 (ru) |
| PT (1) | PT1457492E (ru) |
| RU (1) | RU2284328C2 (ru) |
| TW (1) | TWI333856B (ru) |
| WO (1) | WO2003045953A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2859996B1 (fr) * | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
| ES2371947T3 (es) | 2004-04-30 | 2012-01-11 | Daiichi Sankyo Company, Limited | Proceso para producir taxano pentacíclico. |
| WO2007005829A2 (en) * | 2005-07-01 | 2007-01-11 | Nec Laboratories America, Inc. | Operating system-based memory compression for embedded systems |
| US8785669B2 (en) | 2010-06-30 | 2014-07-22 | Gfv, Llc | Taxane compounds, compositions and methods |
| US8697892B2 (en) | 2010-06-30 | 2014-04-15 | Gfv, Llc | Taxane compounds, compositions and methods |
| EP2447268A1 (en) | 2010-10-29 | 2012-05-02 | INDENA S.p.A. | Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III |
| JP5909089B2 (ja) * | 2011-02-01 | 2016-04-26 | アークレイ株式会社 | 光学結晶、テラヘルツ波発生装置及び方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094940C (zh) * | 1995-04-28 | 2002-11-27 | 第一制药株式会社 | 具有抗肿瘤活性的紫杉酚衍生物 |
| JP2000159757A (ja) * | 1998-12-01 | 2000-06-13 | Dai Ichi Seiyaku Co Ltd | ７−デオキシタキソール誘導体の製造方法 |
| AU761389B2 (en) * | 1999-05-17 | 2003-06-05 | Bristol-Myers Squibb Company | Novel reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel (taxol) and paclitaxel analogues |
| PT1221445E (pt) * | 1999-10-15 | 2008-10-08 | Daiichi Sankyo Co Ltd | Compostos pentacíclicos derivados de taxamos |
| US6677456B2 (en) | 1999-10-15 | 2004-01-13 | Daiichi Pharmaceutical Co., Ltd. | Pentacyclic taxan compound |
| WO2002070512A1 (fr) * | 2001-03-07 | 2002-09-12 | Daiichi Pharmaceutical Co, Ltd. | Procede de fabrication d'un derive d'azetidinone-2 |
-
2002
- 2002-11-29 CA CA2468953A patent/CA2468953C/en not_active Expired - Lifetime
- 2002-11-29 MX MXPA04005192A patent/MXPA04005192A/es active IP Right Grant
- 2002-11-29 EP EP02785977A patent/EP1457492B1/en not_active Expired - Lifetime
- 2002-11-29 DK DK02785977T patent/DK1457492T3/da active
- 2002-11-29 US US10/495,437 patent/US7410980B2/en not_active Expired - Lifetime
- 2002-11-29 JP JP2003547403A patent/JP4310191B2/ja not_active Expired - Fee Related
- 2002-11-29 AT AT02785977T patent/ATE382624T1/de active
- 2002-11-29 CN CNB02823815XA patent/CN1295229C/zh not_active Expired - Fee Related
- 2002-11-29 WO PCT/JP2002/012506 patent/WO2003045953A1/ja active IP Right Grant
- 2002-11-29 PT PT02785977T patent/PT1457492E/pt unknown
- 2002-11-29 KR KR1020047008200A patent/KR100886805B1/ko not_active IP Right Cessation
- 2002-11-29 ES ES02785977T patent/ES2299612T3/es not_active Expired - Lifetime
- 2002-11-29 AU AU2002354126A patent/AU2002354126A1/en not_active Abandoned
- 2002-11-29 DE DE60224440T patent/DE60224440T2/de not_active Expired - Lifetime
- 2002-11-29 TW TW091134817A patent/TWI333856B/zh not_active IP Right Cessation
- 2002-11-29 RU RU2004119547/04A patent/RU2284328C2/ru active IP Right Revival
-
2004
- 2004-06-28 NO NO20042723A patent/NO328559B1/no not_active IP Right Cessation
- 2004-10-28 HK HK04108450A patent/HK1065547A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2468953C (en) | 2010-05-11 |
| DE60224440D1 (de) | 2008-02-14 |
| AU2002354126A1 (en) | 2003-06-10 |
| EP1457492B1 (en) | 2008-01-02 |
| KR20040081426A (ko) | 2004-09-21 |
| DE60224440T2 (de) | 2009-01-02 |
| ES2299612T3 (es) | 2008-06-01 |
| CA2468953A1 (en) | 2003-06-05 |
| EP1457492A1 (en) | 2004-09-15 |
| PT1457492E (pt) | 2008-02-28 |
| CN1295229C (zh) | 2007-01-17 |
| NO20042723L (no) | 2004-06-28 |
| WO2003045953A1 (fr) | 2003-06-05 |
| EP1457492A4 (en) | 2005-03-23 |
| US20050070579A1 (en) | 2005-03-31 |
| JP4310191B2 (ja) | 2009-08-05 |
| JPWO2003045953A1 (ja) | 2005-04-07 |
| US7410980B2 (en) | 2008-08-12 |
| TW200301114A (en) | 2003-07-01 |
| CN1596259A (zh) | 2005-03-16 |
| ATE382624T1 (de) | 2008-01-15 |
| MXPA04005192A (es) | 2005-02-22 |
| NO328559B1 (no) | 2010-03-22 |
| KR100886805B1 (ko) | 2009-03-05 |
| HK1065547A1 (en) | 2005-02-25 |
| RU2284328C2 (ru) | 2006-09-27 |
| TWI333856B (en) | 2010-12-01 |
| DK1457492T3 (da) | 2008-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6905041B2 (ja) | ハリコンドリンｂ類縁体の合成に有用な方法 | |
| BR9608040B1 (pt) | composto taxàide pentacÍclico. | |
| AU2010340799A1 (en) | Darunavir polymorph and process for preparation thereof | |
| RU2004119547A (ru) | Кристаллы производных таксана и способ их получения | |
| Iwamatsu et al. | Copper-catalyzed facile carbon-carbon bond forming reactions at the α-position of α, α, γ-trichlorinated γ-lactams | |
| WO2013114382A1 (en) | Crystalline darunavir | |
| RU2245882C2 (ru) | Производные таксана, способы их получения и фармацевтическая композиция | |
| CN100584459C (zh) | 脱氢松香胺硫脲催化剂在高对映体双手控合成手性化合物中的应用 | |
| ATE521346T1 (de) | Multifunktionelle carbonate und derivate davon | |
| RU94040382A (ru) | Серотонинэргические производные эрголина, способы их получения, фармацевтическая композиция | |
| EP1052257A4 (en) | PROCESS FOR PREPARING OPTICALLY ACTIVE THREO-3-AMINO-1,2-EPOXY COMPOUNDS | |
| Nagao et al. | New methylseleno-promoted ketene-imine cycloaddition reaction. A simplified stereoselective synthesis of penam | |
| CN113999131A (zh) | 可见光促进镍催化烷基c-h键胺化制备酰胺衍生物的方法 | |
| CN108276420B (zh) | 一种8,13-二氢苯并[5,6]色烯并[2,3-b]吲哚类化合物及其合成方法 | |
| JPS6236374A (ja) | チオテトロン酸の製造方法 | |
| CN107074899A (zh) | 改进的氟化工艺 | |
| WO2005000249A3 (en) | Preparation of chemical compounds | |
| Capriati et al. | A highly stereoselective synthesis of α, β-unsaturated oxazolines | |
| García-Ruiz et al. | Synthesis of (–)-and (+)-Gummiferol via Asymmetric Synthesis of Glycidic Amides | |
| JP3921696B2 (ja) | シクロアルカジエン類の不斉エポキシ化反応 | |
| GB1522907A (en) | Carbamates of 2- haloergolines and of 2- haloergolenes and process for the preparation thereof | |
| DE69842005D1 (de) | Kristallines anthracyclin antibiotikum und seine herstellung | |
| Armer et al. | A diastereoselective route to functionalised epoxides by reduction of cyclic β-ketosulphoxides | |
| AU2001241140A1 (en) | Novel crystal of stilbene derivative and process for producing the same | |
| Wollowitz et al. | Additions and Corrections-Free Radical Rearrangement Involving the 1, 2-Migration of a Thioester Group. Model for the Coenzyme B12 Dependent Methylmalonyl-CoA Mutase Reaction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20151130 |
|
| NF4A | Reinstatement of patent |
Effective date: 20171023 |